The global
protein A resin market is projected to reach USD 2.1 billion by 2028
from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast
period. Rising technological advancements primarily drive the growth of this
market in protein A resin, rise in demand for miniaturize protein engineered
product used in disease diagnoses and therapeutics. equipment further supports
the market growth. However, higher initial investment impedes the market
growth.
Protein A
Resin Market: Competitive Landscape and Key Developments
The protein A resin business is very competitive, with both
established companies and newcomers competing for the same market share. As of
2022, the key players operating in the global protein A resin market are
Danaher Corporation (US), Merck KGAa (Germany), Repligen Corporation (US),
Tosoh Bioscience LLC (Japan), Thermo Fisher Scientific (US), Agilent
Technologies Inc. (US), and PerkinElmer (US) among others.
Get PDF Brochure With Latest Insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
Danaher Corporation (US)
Danaher Corporation is a US-based company that designs,
manufactures, and markets medical, industrial, and commercial products and
services. The company operates through three business segments, namely, Life
Sciences, Diagnostics, and Environmental & Applied Solutions. The Life
Sciences business segment offers protein A resin products. This segment is
further classified into Filtration, Mass Spectrometry, Cellular Analysis, Lab
Automation & Centrifugation, Microscopy, and Genomics Consumables. In FY
2021, the US accounted for 38.3% of the company’s revenue, followed by China
(13.5%), Germany (5%), and all other countries (43.2%). The company's presence
across diverse geographies shields it from risks associated with adverse
economic trends in a single region. It also provides it with exposure to a
large addressable market, thus enhancing its topline.
Merck KGAA (Germany)
Merck KGaA is another major player in the protein A resin
market. The company is a leading provider of chromatography consumables across
the globe. It primarily focuses on expansions and new product launches as its
key growth strategies to expand its presence in the global market. Merck has a
significant focus on innovation. Over the last few years, the company has
increased its R&D activities with a focus on providing its customers with
advanced products. Through strong R&D, the company is extending its patent
portfolio, which can help Merck gain an advantage over its competitors. Merck
is consistently introducing new chromatography products in the market. The
company is also focused on enhancing its geographic presence through
expansions.
Objectives of the Study
·
To define, describe, and forecast the protein A
resin market on the basis of product, type, application, end user, and region
·
To provide detailed information regarding the
major factors influencing the growth potential of the global market (drivers,
restraints, opportunities, challenges, and trends)
·
To analyze the micro markets with respect to
individual growth trends, future prospects, and contributions to the global
market
·
To analyze key growth opportunities in the
global market for key stakeholders and provide details of the competitive
landscape for market leaders
·
To forecast the size of market segments and/or
subsegments with respect to five major regions, namely, North America (US and
Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia
Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), and rest
of the world.
·
To profile the key players in the global market
and comprehensively analyze their market shares and core competencies
·
To track and analyze the competitive
developments undertaken in the global protein A resin market, such as product
launches, agreements, expansions, and & acquisitions
Buy This Complete Business Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=19196962
Global Protein A Resin Market – Regional Scope
The global Protein A resin market is segmented into five
major regions, namely, North America, Europe, Asia Pacific, Latin America, and
the Middle East & Africa. Among these, the North America region is expected
to hold the largest share in the global Protein A resin market. This can be
attributed to the presence of well-established biopharmaceutical companies in
the region and the availability of advanced infrastructure for
biopharmaceutical manufacturing. Moreover, the rapid growth of the biopharmaceutical
industry in the region is also expected to propel the growth of the Protein A
resin market in North America.
Europe is the second-largest region in the global Protein A
resin market, due to the presence of a large number of biopharmaceutical
companies and contract research organizations in the region. The Asia Pacific
is expected to be the fastest-growing region in the global Protein A resin
market, owing to the increasing demand for biopharmaceuticals in the region.
The growing research and development activities in the region are also expected
to contribute to the growth of the Protein A resin market in the region.
Recent Developments
·
In September 2022, As part of its charitable
efforts through the Agilent Foundation, Agilent Technologies partnered with
Delaware State University (DSU) to boost the number of minority students who
choose STEM careers.
·
In October 2021, Tosoh Biosciences LLC completed
the acquisition of Semba Biosciences, a privately held leading innovator in the
field of multi-column chromatography (MCC) instrumentation and technology for
the downstream purification of biologics.
·
In September 2021, Repligen and Navigo completed
their co-development of a novel affinity ligand that addresses aggregation
issues associated with pH-sensitive antibodies and Fc-fusion proteins. This
ligand, NGL-Impact HipH, is produced and supplied to Purolite for use in a
platform usage resin product.
·
In May 2021, The Life Sciences business of GE
Healthcare was acquired by Danaher Corporation and rebranded as Cytiva.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19196962
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine offering to drive
supernormal growth for progressive organizations in the B2B space. We have the
widest lens on emerging technologies, making us proficient in co-creating
supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion
of new revenue streams that are substituting existing revenue streams in this
decade alone. We work with clients on growth programs, helping them monetize
this $25 trillion opportunity through our service lines - TAM Expansion,
Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account
Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive
ecosystem. Our insights and strategies are molded by our industry experts,
cutting-edge AI-powered Market Intelligence Cloud, and years of research. The
KnowledgeStore™ (our Market Intelligence Cloud) integrates our research,
facilitates an analysis of interconnections through a set of applications,
helping clients look at the entire ecosystem and understand the revenue shifts
happening in their industry.
The Wall